Rite Aid Corporation (NYSE: RAD) and drug supplier McKesson Corp (NYSE: MCK) have reached a settlement, securing the continued fulfillment of customer prescriptions throughout Rite Aid's
The FDA approved Ardelyx Inc's (NASDAQ: ARDX) Xphozah (tenapanor), the first and only phosphate absorption inhibitor, indicated to reduce serum phosphorus in adults with chronic kidney disease (CKD) on dialysis as add-on therapy in patients who have inadequate response to phosphate binders or
Takeda Pharmaceutical Co Ltd (NYSE: TAK) released topline data from the Phase 3 ADMIRE-CD II study, assessing Alofisel (darvadstrocel) for complex Crohn's Perianal Fistulas (CPF).
Neuralink's N1 implant is cosmetically invisible and is intended to record and transmit brain signals wirelessly to an app that decodes movement intention.
Cantor Fitzgerald initiated coverage on Bluebird Bio Inc (NASDAQ: BLUE), saying sickle cell disorder (SCD) has been a hotbed of development for genetic medicines as the company's lovo-cel marches towards the U.S. market.
U.S. medical devices manufacturer Edwards Lifesciences Corp (NYSE: EW) is reportedly under the scrutiny of EU antitrust regulators for its patent practices and policies aimed at thwarting copycat devices that prompted a series of dawn raids by EU authorities last month.
U.S. District Judge M. Casey Rodgers, overseeing the mass tort litigation involving 3M Company's (NYSE: MMM) $6 billion settlement for military earplug-related hearing damage, has warned about an identity theft scam targeting claimants.